Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

American Journal of Psychiatry

Volumn 155, Issue 1, 1998, Pages 54-61

  Tariot, Pierre N ^a   Erb, Rosemary ^b   Podgorski, Carol Ann ^b   Cox, Christopher ^b   Patel, Shirish ^b   Jakimovich, Laura ^b   Irvine, Carrie ^b  

^a Monroe Community Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE;

AGED; AGGRESSIVENESS; AGITATION; ARTICLE; ATAXIA; BEHAVIOR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TIC; VERTIGO;

EID: 0031974390     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.1.54     Document Type: Article

References (34)

1. Tariot PN, Mack JL, Patterson MB, Edland SD, Weiner MF, Fillenbaum G, Blazina L, Teri L, Rubin E, Mortimer JA, Stern Y, Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease: The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995; 152:1349-1357
2. Cohen-Mansfield J: Agitated behaviors in the elderly, II: preliminary results in the cognitively deteriorated. J Am Geriatr Soc 1986; 34:722-727
3. Reisberg B, Franssen E, Sclan SG: Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer's disease: a study of 120 patients using the BEHAVE-AD. Bull Clin Neuroscience 1989; 54:95-112
4. Cohen-Mansfield J, Billig N: Agitated behaviors in the elderly, I: a conceptual review. J Am Geriatr Soc 1986; 34:711-721
5. Rovner BW, Kafonek S, Filipp L, Lucas MJ, Folstein MF: Prevalence of mental illness in a community nursing home. Am J Psychiatry 1986; 143:1446-1449
6. Marx MS, Cohen-Mansfield J, Werner P: A profile of the aggressive nursing home resident. Behavior, Health, and Aging 1990; 1:65-73
7. Tariot PN, Podgorski CA, Blazina L, Leibovici A: Mental disorders in the nursing home: another perspective. Am J Psychiatry 1993; 150:1063-1069
8. Tariot PN, Schneider LS, Katz IR: Anticonvulsant and other non-neuroleptic treatment of agitation in dementia. J Geriatr Psychiatry Neurol 1995; 8(suppl 1):S28-S39
9. Burton LC, Rovner BW, German PS, Brant LJ, Clark RD: Neuroleptic use and behavioral disturbance in nursing homes: a 1-year study. Int Psychogeriatr 1995; 7:535-545
10. Schneider LS, Pollock VE, Lyness SA: A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563
11. Tariot PN, Erb R, Leibovici A, Podgorski CA, Cox C, Asnis J, Kolassa J, Irvine C: Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study. J Am Geriatr Soc 1994; 42:1160-1166
12. Lemke MR: Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics. J Clin Psychiatry 1995; 56: 354-357
13. Chambers CA, Bain J, Rosbottom R, Ballinger BR, McLaren S: Carbamazepine in senile dementia and overactivity - a placebo controlled double blind trial. IRCS Med Sci 1982; 10:505-506
14. Overall JE, Gorham DR: Introduction: the Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 1988; 24:97-98
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
16. Tariot PN, Frederiksen K, Erb R, Leibovici A, Podgorski CA, Asnis J, Cox C: Lack of carbamazepine toxicity in frail nursing home patients: a controlled study. J Am Geriatr Soc 1995; 43: 1026-1029
17. Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL: A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry 1993; 150:1806-1812
18. Greenblatt DJ: Sedative-hypnotics: sleep disorders in the elderly, in Physicians' Handbook on Psychotherapeutic Drug Use in the Aged. Edited by Crook T, Cohen G. New Canaan, Conn, Mark Powley Assoc, 1981, pp 59-65
19. Frederiksen K, Tariot P, DeJonghe E: Minimum Data Set Plus (MDS+) scores compared with scores from five rating scales. J Am Geriatr Soc 1996; 44:305-309
20. Gleason RP, Schneider LS: Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics. J Clin Psychiatry 1990; 51:115-118
21. Rhoades HM, Overall JE: The semistructured BPRS interview and rating guide. Psychopharmacol Bull 1988; 24:101-104
22. Overall JE, Beller SA: The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research, I: factor structure on an inpatient unit. J Gerontol 1984; 39:187-193
23. Aarsland D, Cummings JL, Yenner G, Miller B: Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease. Am J Psychiatry 1996; 153:243-247
24. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Rockville, Md, US Department of Health, Education, and Welfare, 1976, pp 217-222
25. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D: The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986; 143:35-39
26. Lawton MP, Brody E: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9:179-186
27. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
28. Auer SR, Sclan SG, Yaffee RA, Reisberg B: The neglected half of Alzheimer disease: cognitive and functional concomitants of severe dementia. J Am Geriatr Soc 1994; 42:1266-1272
29. Post RM, Weiss SRB, Chuang D-M: Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium. J Clin Psychopharmacol 1992; 12(Feb suppl 1):23S-35S
30. Maitre L, Baltzer V, Mondadoni C, Olpe HR, Baumann PA, Waldmeier PC: Psychopharmacological and behavioral effects of antiepileptic drugs in mood disorders, in Anticonvulsants in Affective Disorders. Edited by Emrich HM, Okuma T, Muller AA. Amsterdam, Elsevier, 1984, pp 3-13
31. Elphick M, Anderson SMP, Hallis KF, Grahame-Smith DG: Effects of carbamazepine on 5-hydroxytryptamine function in rodents. Psychopharmacology (Berl) 1990; 100:49-53
32. Rodgers RJ, Depaulis A: GABAergic influences on defensive fighting in rats. Pharmacol Biochem Behav 1982; 17:451-456
33. Teri L, Lodgson RG: Methodologic issues regarding outcome measures for clinical drug trials of psychiatric complications in dementia. J Geriatr Psychiatry Neurol 1995; 8(suppl 1): S8-S17
34. Porsteinsson A, Tariot PN, Erb R, Gaile S: An open trial of valproate for agitation in geriatric neuropsychiatric disorders. Am J Geriatr Psychiatry (in press)